← brief for 2026-10-25 · Slowing decline

Acute eGFR Changes With Finerenone Examined in a Prespecified Analysis of FINE-ONE.

Article B Peer reviewed Small trial

Key takeaways

This analysis looked at 242 people with type 1 diabetes and kidney disease. They were given the drug finerenone or a placebo. The drug caused a small, temporary drop in kidney filtering rate in the first month. This drop reversed after the treatment ended, suggesting it is a safe side effect.

Who did this work

Cherney DZI · Yi TW · Heerspink HJL · Ji L · McGill JB · Rossing P · Tuttle KR · Bech JN · Fiorina P · Power A · Schousboe K · Selby NM

Source

Article · PubMed, the drug frontier · 2026 Sep 16
https://pubmed.ncbi.nlm.nih.gov/42927222/